Drug innovation

#Artificial intelligence (AI) #Clinical development #Coronado Research #Drug innovation

The impact of AI on drug discovery and development

DDW’s Megan Thomas speaks with Dr Jennifer Bradford, VP, Head of Data Science at Coronado Research, about the impact of artificial intelligence (AI) on the clinical development process, how to overcome common barriers to adoption and the developments with the potential to accelerate innovation. MT: How do you envision AI… Read More

#Exclusive Content

Protesting against health inequalities
#ABPI #Collaboration #Drug discovery #Drug innovation #NHS #Pharma #UK

NHS/industry collaboration could improve access to drugs

Collaborative working between the NHS and industry could reduce variations in uptake of innovative treatments across the UK, a joint report from NHS Confederation and ABPI argues.   Analysis from the report has shown a significant variation in access to innovative medicines for patients across the UK and… Read More

#News

#Drug development #Drug innovation #Funding #Investment

CatSci secures £4.5 million funding deal for drug development 

CatSci, a partner for medicines development, has secured £4.5 million of investment to expedite the development and launch of what it calls its life-changing therapeutics.  The company develops economically and environmentally sustainable drug manufacturing processes that enable its global pharmaceutical customers to create affordable small molecule therapeutics… Read More

#News

#Biopharmaceuticals #Drug development #Drug innovation #Funding

Key take-aways from new R&D trends report 

As the global Covid-19 pandemic enters its third year, the life sciences innovation system is setting new records in the level of investment, activity, and scientific progress, according to the IQVIA Institute. In its report, Global Trends in R&D: Overview through 2021, the IQVIA assesses the trends in new drug… Read More

#News #Trends & Analysis

Boston
#Comment #Drug discovery #Drug innovation #Lab automation #SLAS2022

From the editor: Being part of the innovation 

The Winter issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 February. DDW Editor in Chief Lu Rahman comments.  There is huge excitement within the DDW team regarding the SLAS2022 International Conference and Exhibition in Boston on 5-9 February. With Omicron throwing a spanner… Read More

#Editor's Choice #Exclusive Content #News

#Drug development #Drug innovation #Microbiology

BaseClear appoints new CSO to lead its science and innovation arm 

BaseClear has appointed Alex Van Belkum as Chief Scientific Officer. He is a molecular microbiologist with extensive experience in molecular- and culture-based diagnostics, antimicrobial resistance testing and clinical microbiology. He will lead BaseClear’s science and innovation arm together with Innovation Manager Walter Pirovano and a team of PhD-level Product Managers.   Official comment… Read More

#News

#Biopharma #Biotechnology #Drug innovation #Pharmaceuticals #Report #Research

Pharmaceuticals and biotech lead UK university innovation 

University technology and innovation is driving the UK's status in pharmaceuticals and biotechnology, according to GovGrant’s University Spinouts Report 2021.  The report  According to the new report, the pharmaceuticals and biotechnology sector dominates the top ten spinout companies of the last decade, ranked by valuation. Pharma and biotech companies within the top… Read More

#News #Trends & Analysis

#Cancer research #Diagnostics #Drug innovation #Healthcare

Collaboration to produce an ADC to treat neuroendocrine cancers 

Novasep, a supplier of services and technologies for the life sciences industry, and McSAF, a French biotech specialised in bioconjugation tools to design bio drugs for health and diagnostics, have collaborated for the preclinical production of ADCITMER, a next-generation Antibody-Drug Conjugate (ADC) to treat neuroendocrine cancers.   What has been done?… Read More

#News

#Drug discovery #Drug innovation #ELRIG #Events #Innovation

ELRIG UK’s Drug Discovery 2021 

Given the unexpected couple of years we have had as a result of the Covid-19 pandemic, the drug discovery sector is no doubt looking forward to an in-person event at last. ELRIG UK’s Drug Discovery 2021 will take place at the ACC, Liverpool, UK on 19-20 October.  DDW has teamed up with ELRIG UK to produce… Read More

#Editor's Choice #News

#Biopharmaceuticals #Biotechnology #Drug innovation

Sciex launches capillary electrophoresis solution

Sciex has launched a capillary electrophoresis solution, the BioPhase 8800 system. The multi-capillary system for CE-SDS processes eight samples simultaneously, retaining sample integrity and delivering consistent results.  The development of biopharmaceutical therapies requires the ability to measure and monitor critical quality attributes in short timelines. The BioPhase 8800… Read More

#News

#Data #Drug discovery #Drug innovation #Life sciences

Paradigm4 launches multi-omics app for advanced cross-study analysis

Paradigm4 has launched Reveal: Multi-Omics, an app which allows researchers to undertake advanced, cross-study analyses and enable quick searches for genes and proteins across integrated public reference and proprietary datasets. It is built on top of Paradigm4’s SciDB analytics platform, designed for rapid data slicing that enables scientific data modelling,… Read More

#News

#Drug development #Drug innovation #Funding #Research #Therapeutics

Orbit Discovery plans growth in peptide discovery business

Orbit Discovery has raised US$7.6 million which will be used to accelerate its growth as a provider of peptide discovery services to the biotechnology and pharmaceutical industry. Orbit Discovery’s novel bead-based and microfluidic technology platform enables the screening of peptide libraries for target binding and subsequent activity in cell-based functional… Read More

#News

#Cancer research #Drug development #Drug discovery #Drug innovation #Oncology #Research #Therapeutics

Sitting down with… Mari Scheiffele, Novartis

Mari Scheiffele is the General Manager for Oncology in the UK & Ireland at Novartis, responsible for launching innovative oncology therapies that can help to change the lives of people living with different types of cancer. She speaks to Lu Rahman about her passion for working with her teams to… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News #Opinion

#Cell and gene therapy #Drug delivery #Drug development #Drug innovation #Life sciences

RoslinCT selected as vaccines and advanced therapies training centre

RoslinCT has been confirmed as a National Training Centre, part of the Department for Business, Energy & Industrial Strategy (BEIS) sponsored Advanced Therapies Skills Training Network (ATSTN) initiative. The organisation is the second National Training Centre confirmed as part of the ATSTN initiative, which was set up to develop vaccine… Read More

#News

#Cancer #Cancer research #Drug delivery #Drug innovation #London Cancer Hub #Pharmaceuticals

Global hub for cancer research, treatment and commercial enterprise

Andy Carr, Business Development Manager at The Institute of Cancer Research, London, introduces the new Innovation Gateway at The London Cancer Hub in Sutton, south London, to DDW’s Megan Thomas. MT: I understand the establishment of the Innovation Gateway is underway. What is the progress and when is it due… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News

#Biopharmaceuticals #Covid-19 #Drug delivery #Drug development #Drug discovery #Drug innovation #Immunology / Virology & Vaccines #Pharma #Pharmaceuticals #Vaccines

Integration at its best: Dalton Pharma outlines its CDMO expertise

Dalton Pharma Services, a contract development and manufacturing organisation (CDMO) offers expertise in drug discovery, formulation and process development, custom synthesis, and GMP manufacturing services. Lu Rahman spoke to CEO, Peter Pekos about the company’s ongoing expertise. LR: The company has experience supplying the needs of the orphan drug field… Read More

#Exclusive Content #News #Opinion